New onset of generalized myasthenia gravis developed after a new coronavirus infection (COVID-19)
Development of various immune-mediated neurological complications after a viral infection is of particular interest to medical society during a pandemic of COVID-19. It was found that SARS-CoV-2 has the ability to cause hyperstimulation of the immune system, thereby initiating developing of autoimmu...
Saved in:
| Main Authors: | T. M. Alekseeva, P. Sh. Isabekova, M. P. Topuzova, N. V. Skripchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2021-12-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/1279 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgical effect and prognostic factors of myasthenia gravis with thymomas
by: Wenxin Tian, et al.
Published: (2020-05-01) -
COVID‐19‐associated AMPA‐R and CRMP‐5 autoimmune encephalitis in a patient with thymoma and myasthenia gravis
by: Jenelle Raynowska, et al.
Published: (2023-03-01) -
The role of regulatory B cell/T follicular helper cell balance in thymoma and thymoma-associated myasthenia gravis
by: Peng Zhang, et al.
Published: (2025-07-01) -
Myasthenia gravis complicated by Graves’ disease: a case report
by: Larrey Kasereka Kamabu, et al.
Published: (2025-07-01) -
Effects of exosomes of paratumoral thymus epithelial cells on Treg cell function in patients with thymoma-associated myasthenia gravis
by: CHEN Liuling, et al.
Published: (2024-07-01)